Erythropoietin in Infants With Hypoxic Ischemic Encephalopathy (HIE)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

June 30, 2009

Conditions
Hypoxic Ischemic Encephalopathy
Interventions
DRUG

Human recombinant erythropoietin

Epo dse is 2500 IU/kg subcutaneous daily for 5 days.

PROCEDURE

EEG and Brain MRI

EEG to be done twice in hte first 48 hours and at 2-3 weeks. MRI to be done at 3 weeks of age.

BIOLOGICAL

Nitric oxide measurement in the blood

Concentration of nitric oxide is measured in the blood at enrollment. For the 2 groups with asphyxia, measurement to be repeated in 2 weeks.

Trial Locations (1)

Unknown

Tanta University Faculty of Medicine, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT00945789 - Erythropoietin in Infants With Hypoxic Ischemic Encephalopathy (HIE) | Biotech Hunter | Biotech Hunter